Reforms of Medical Tariff in Iran: A Sociological Analysis of the Obstacles

Document Type : Research Article

Authors

1 Department of Coopeartion and Social Welfare, Faculty of Social Sciences, Allameh Tabataba’i University, Tehran, Iran

2 Department of Epidemiology, Faculty of Health, Tehran University of Medical Sciences, Tehran, Iran

10.22059/jisr.2023.352257.1363

Abstract

The purpose of this sociological study is to investigate the obstacles to reforming medical tariffs in Iran's health system. To comprehend the impediments to reforming medical tariffs, we will employ Habermas' theory of dialogue democracy and conduct an analysis of stakeholders. This theory emphasizes the importance of open dialogue and participatory processes in complex system decision-making, such as the health system.
This study employs in-depth interviews as its primary method of data acquisition. The data was analyzed using the stakeholder analysis table, which included the dimensions of knowledge, position, interest, and influence. This study collects data from both existing and new interviews.
The findings indicate that transparency is a significant obstacle in the policymaking process, and that stakeholders need more knowledge and information about the policymaking process. The position of stakeholders toward the proposed reforms is one of opposition and resistance. Conflicting interests within the health system pose the greatest barrier to policymaking, according to an analysis of interests. The power analysis reveals that the health system's power structure is centralized, with a limited number of influential policymakers having competing interests in regulating the system. The conclusion of the study is that the top-down approach to policymaking in the health system, which is dominated by competing interests and the erosion of public spheres and civil institutions, results in the concentration of power. On the other hand, a participatory and dialogue-based approach increases the likelihood of successful policy implementation and the protection of the interests of all stakeholder groups. To establish a collaborative public sphere within the health system, policymakers should restore the authority of civil and professional organizations, such as the medical council.
The top-down approach to policymaking, which is influenced by competing interests and centralized authority, has led to opposition from healthcare providers. Service providers must be involved in the successful implementation of health equity policies. Consequently, their participation in the policymaking process is essential to its success.

Keywords

References

  • Abdolmaleki, H., (2022). Letter from minister of Cooperatives, Labour and Social Welfare to the president, Access date: Oct 2022, URL: http://sobhetehran.com/fa/pages/?cid=154399
  • The Islamic Republic of Iran Medical Council (2022), Statement of The Islamic Republic of Iran Medical Council on medical tariffs, access date: Oct 2022, URL: https://irimc.org/news/id/
  • Worl Bank data, Access date: Oct 2022, URL: https://data.worldbank.org
  • Abdolahzadeh, N., Bolandhematan, K., Shirbagi, N., Critical Ethnography of the Commodification of Education in the Suburbs of Sanandaj City, Quarterly of Social Studies and Research in Iran, 11(4), 993-1008. https://doi.org/10.22059/jisr.2022.326306.1224 (In Persian)
  • Aboutorabi, A., Radinmanesh, M., Rezapour, A., Afshari, M., & Taheri, G. (2020). A comparison of global surgery tariffs and the actual cost of bills at Hazrate Rasoole Akram educational and medical center. Cost Effectiveness and Resource Allocation, 18, 1-10.https://doi.org/10.1186/s12962-020-00232-w
  • Brugha, R., & Varvasovszky, Z. (2000). Stakeholder analysis: a review. Health Policy and Planning, 15(3), 239-246.https://doi.org/10.1093/heapol/15.3.239
  • Dimova, A., Rohova, M., Hasardzhiev, S., & Spranger, A. (2018), An innovative approach to
    participatory health policy development in Bulgaria: The conception and first achievements of the Partnership for Health. Health Policy, 122(2), 81-86. https://doi.org/10.1016/j.healthpol.2017.11.002
  • Gilson, L., Erasmus, E., Borghi, J., Macha, J., Kamuzora, P., & Mtei, G. (2012). Using stakeholder analysis to support moves towards universal coverage: lessons from the SHIELD project. Health Policy and Planning, 27(suppl_1), i64-i76.https://doi.org/10.1093/heapol/czs007
  • Habermas, J. (1989). The new conservatism: cultural criticism and the historians’ debate, trans. Shierry Weber Nicholsen, Cambridge: Polity.
  • Hartmann, D., Morrison, T. M., & Harebottle, C. (2012, June). Development Of A Tariff Tool For Medical Aids Within Africa. In Computers and Industrial Engineering 42.
  • Malek Afzali, H., & Bahreyni, F., & Ala Aldini, F., & Forouzan, A. (2007). Health System Priorities Based On Needs Assessment & Stakeholders’ Participation In I.R. Iran. Hakim Research Journal, 10(1), 13-19. http://hakim.tums.ac.ir/article-1-326-fa.html (In Persian)
  • Mishler, E. G. (1984). The discourse of medicine: Dialectics of medical interviews(Vol. 3). Greenwood Publishing Group.
  • Rosenfeld, M., & Arato, A. (Eds.). (1998). Habermas on law and democracy: Critical exchanges. Berkeley: University of California Press.
  • Scambler, G. (Ed.). (2001). Habermas, critical theory and health. London: Routledge.
  • Shahrzad, Z., & Bastani, S., & Vedadhir, A. (2022). Coping with powerlessness in the experience of illness: A narrative study of complementary and alternative medicine users. Social Studies and Research in Iran, 10(4), 999-1028. https://doi.org/10.22059/jisr.2021.317754.1173 (In Persian)
  • Waitzkin, H. (1989). A critical theory of medical discourse: Ideology, social control, and the processing of social context in medical encounters. Journal of Health and Social Behavior, 220-239. https://doi.org/10.2307/2137015

Files

Share

How to cite

Statistics